Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

13.97
Delayed Data
As of 4:00pm ET
 +0.21 / +1.53%
Today’s Change
9.16
Today|||52-Week Range
17.55
-17.09%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Nektar Therapeutics have a median target of 17.00, with a high estimate of 20.00 and a low estimate of 14.00. The median estimate represents a +21.69% increase from the last price of 13.97.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Nektar Therapeutics. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.32
Sales
$31.7M
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -129.46%
 
 
 
 
 
 
Growthannually -56.21%
 
 
 
 
 
 

Sales

Growthquarterly -46.18%
 
 
 
 
 
 
Growthannually -25.78%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.